|
Cleveland, OH, July 20, 2011 - Arteriocyte receives $1 Million award from Ohio Third Frontier Program to advance its NANEX™ technology toward clinical use. read more ...
Cleveland, OH, June 7, 2011 - Arteriocyte and the US Army Institute of Surgical Research (USAISR) sign a CRADA to speed development of Cellular Therapies for Orthopaedic Trauma. read more ...
Cleveland, OH, January 28, 2011 - Arteriocyte announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb
Ischemia (CLI). read more ...
Cleveland, OH, May 20, 2009 - Arteriocyte Medical Systems announced today a strategic investment in Control Medical Technology, a medical device developer based in Park City, Utah. read more ...
Thursday, November 08, 2007 - Arteriocyte Medical Systems Forms Strategic Partnership with Medtronic including Acquisition of the Magellan Platelet Rich Plasma Business. read more ...
Thursday, October 25, 2007 - Arteriocyte, Inc. and DW Healthcare Partners, today announced the formation of Arteriocyte Medical Systems, Inc., launching the company with a $10 million growth capital investment. read more ...
|